An early look into HS
Take a deep dive into hidradenitis suppurativa in two Innovation Academy Sunrise Sessions.

SUN09 – Innovative and Advanced Management of Biologics and Small Molecule Inhibitors in Hidradenitis Suppurativa and Beyond
7:30–8:30 a.m. | Saturday, July 12
Grand Hall K
SUN15 – Phenotyping Hidradenitis Suppurativa (HS): Findings of a Collaborative Artificial Intelligence (AI) Initiative
7:30–8:30 a.m. | Sunday, July 13
Regency A
The 2025 AAD Innovation Academy will feature two Sunrise Sessions dedicated to hidradenitis suppurativa (HS). One will focus on pinpointing HS within populations and the other will review new and upcoming therapies for patients with HS.
Alexandra Charrow, MD, FAAD
Dr. Charrow is assistant professor of dermatology at Harvard Medical School and director of the Hidradenitis Suppurativa and Neutrophilic Dermatoses Clinic. She said attendees can expect to learn the what, when, where, why, and how of managing HS with innovative, personalized solutions.
Steven Daveluy, MD, FAAD
Register today for the 2025 AAD Innovation Academy in Chicago, July 10-13, and add these and other sessions to your schedule.